Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • QBTS vs MRNA✓SelectedUSD · MRNAQBTS vs MRNA performance historyLatest closeAs of-4.94%11/19
Stock and ETF performance explorer

QBTS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-25.8%
MRNA return
-24.9%
Excess return
-0.9%
Maximum drawdown
-96.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.9%+1.3%-6.2%-5.1%
7D-25.7%-13.8%-11.9%-24.3%
30D-37.9%-17.7%-20.3%-36.4%
3M-62.2%+14.3%-76.5%-63.0%
6M-59.8%+336.0%-395.8%-71.3%
YTD-72.0%+575.9%-648.0%-82.4%
1Y-68.8%+724.4%-793.2%-81.3%
3Y+751.0%+160.8%+590.2%+505.3%
5Y-25.8%-24.4%-1.4%-44.2%
All-25.8%-24.9%-0.9%-44.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling